Recent Updates
Recently added Catalysts
ABT Positive Sentiment Score: 72/100

Abbott's 'Above the Bias' Film Reveals Misconceptions Can Impact Diabetes Care 'One cupcake won't kill you,' 'I'm going to get diabetes just looking at that,' 'That person doesn't look like they have diabetes.' New survey...

Key Takeaway: Abbott has launched the 'Above the Bias' initiative, including a film that addresses misconceptions affecting diabetes care. Survey data indicates that stigma and stereotypes significantly impact the health management of people living with diabetes. The initiative seeks to cultivate a deeper understanding of the challenges faced by individuals with diabetes and highlights the importance of both technological and communal support. Abbott continues to innovate in diabetes care with its FreeStyle Libre continuous glucose monitoring system.

Market Sentiment Analysis

POSITIVE FACTORS

  • Abbott's 'Above the Bias' initiative aims to reduce stigma around diabetes.
  • The new film shines a light on common misconceptions affecting care.
  • Survey results highlight the need for compassionate understanding of diabetes.
  • The company is committed to improving the lives of those living with diabetes through technology and advocacy.

Full Press Release Details

ABBOTT PARK , Ill. , Feb. 4, 2025 /PRNewswire/ -- 'One cupcake won't kill you,' 'I'm going to get diabetes just looking at that,' 'That person doesn't look like they have diabetes.' New survey results and a film released today by Abbott highlight how everyday comments like these may affect people living with diabetes.
People living with diabetes – which now includes 1 in 6 adults in America 2 – face many barriers to receiving care. Survey data reveal that the misconceptions and stereotypes around the condition can weigh heavily on the minds of those living with diabetes, creating one more barrier and potentially preventing them from managing their health. 1
"How many times have we heard 'That looks like diabetes on a plate' when we're watching a movie, eating at a restaurant or scrolling through social media?," said Dr. Susan Guzman , Behavioral Diabetes Institute co-founder, clinical psychologist, and diabetes specialist. "After more than two decades of research and working with people managing diabetes, I can tell you that misconceptions around diabetes take a real toll on people. If we want to help people have healthier lives, we have to recognize where and how bias around diabetes exists and promote a compassionate and fact-based understanding of diabetes."
Data 1 from a survey of more than 2,600 people living with diabetes across eight countries, including the U.S., highlights they may not be getting the care they need due to the shame and stigma around their condition, which can lead to real and often unnoticed health consequences:
Additional biometric testing revealed that nearly 40% of individuals had an elevated physiological response to stigmatizing statements, even if they don't show outward signs or expressions. 1
But while words can hurt, they can also help.
Above the Bias Abbott's new Above the Bias initiative aims to help others see the world from the perspective of someone living with diabetes. The initiative builds upon efforts by several diabetes organizations, patient advocacy groups, and experts that continue to work to reduce stigma about diabetes . 3 People can learn more about Above the Bias and watch the film at AboveBias.com .
"From the very early days of Libre, it's been our job to make living with diabetes easier," said Chris Scoggins , executive vice president of Abbott's diabetes care business. "But technology alone can't fix every barrier that people face. We're committed to doing our part, but we can't do it alone. We need the ongoing help of others to support people living with diabetes, so they can get the care they need to manage their health."
About FreeStyle Libre: Abbott continues to pioneer ground-breaking technology to support people living with diabetes. The company revolutionized diabetes care 10 years ago with its world-leading FreeStyle Libre continuous glucose monitoring portfolio, which today is used by about 7 million people in more than 60 countries. 4 People use Libre to see their glucose numbers in real-time, providing insights into how food, activity, or insulin impacts their glucose to help them make progress on their health goals.
About Abbott: Abbott is a global healthcare leader and continues to pioneer ground-breaking technology and initiatives to support people live more fully at all stages of life. The company revolutionized diabetes care 10 years ago with its world-leading Libre continuous glucose monitoring portfolio, which today is used by 7 million people in more than 60 countries. 4 Abbott's other technologies span the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries.
Connect with us at Abbott.com and on LinkedIn , Facebook , Instagram , X and YouTube .
Abbott Media: Katie Walker, [email protected]
Abbott Financial: Michael Comilla, [email protected]
Product for prescription only; for Important Safety Information, please visit FreeStyleLibre.us .

21 %

Frequently Asked Questions

How does stigma affect people with diabetes?

Stigma and misconceptions about diabetes can prevent individuals from receiving necessary care.

What percentage of adults in the U.S. have diabetes?

Currently, 1 in 6 adults in the U.S. are living with diabetes.

What is Abbott's Above the Bias initiative?

The Above the Bias initiative aims to reduce stigma and promote understanding of diabetes.

How does FreeStyle Libre help diabetes management?

FreeStyle Libre provides real-time glucose monitoring, helping users manage their health.

Who can benefit from Abbott's diabetes care technology?

About 7 million people worldwide currently use Abbott's FreeStyle Libre technology.

Last updated: Feb 4, 2025